Concepedia

Author

Xinjun Liang

Sun Yat-sen UniversityORCID

Also Known As

X F Liang, X. Liang, Xiao-Ya Liang, Xin-Jun Liang, Xinjun Liang, Xu-Ran Liang, xinjun Liang

22

Publications

461

Citations

8

H-Index

39

Concepts

All Affiliations

Sun Yat-sen UniversitySun Yat-sen Memorial HospitalJohannes Gutenberg University MainzFirst Affiliated Hospital of Xi'an Jiaotong UniversityHubei Cancer Hospital
XL

About

Xinjun Liang is an author at Sun Yat-sen University specializing in cell biology, medicine, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

323

2

Cell Biology

4

4

323

3

Social Sciences

1

1

24

4

Immunology

1

1

109

5

Neurology

1

1

24

Xinjun Liang

×

8

Publications

439

Citations

8

H-Index

YearCitations

Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

Weiguang Wu, Zhongqiu Lin, Zhiqiang Zhuang,

European Journal of Cancer Prevention

2008

169

β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8<sup>+</sup>T cells through regulation of IL-10

Chunmei Fu, Xinjun Liang, Weiguo Cui,

Proceedings of the National Academy of Sciences

2015

109

β-Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells

Xinjun Liang, Chunmei Fu, Weiguo Cui,

Journal of Leukocyte Biology

2013

69

Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury

Qingqi Meng, Xinjun Liang, Peng Wang,

Neuroscience Letters

2011

24

Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma

Yu Guo, Jing Wang, Hua Li,

Journal of Gastroenterology and Hepatology

2015

21

Effects of Survivin on cell proliferation and apoptosis in MG‐63 cells in vitro

Xinjun Liang, Mingxu Da, Zhiqiang Zhuang,

Cell Biology International

2008

21

CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial

Jia Liu, Jianwei Yang, Yuping Sun,

Nature Medicine

2025

15

The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial

Dan‐Yun Ruan, Hao‐Xiang Wu, Suxia Luo,

Nature Medicine

2025

11

Page 1